GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability

References

• Gray JA, Roth BL. The pipeline and future of drug development in schizophrenia. Mol. Psychiatry12(10), 904–922 (2007).
   PubMed Web of Science ®Google Scholar
• Costa E, Davis JM, Grayson DR, Guidotti A, Pappas G, Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis.8(5), 723–742 (2001).
   PubMed Web of Science ®Google Scholar
• Akbarian S, Kim JJ, Potkin SG et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry52(4), 258–266 (2000).
   Google Scholar
• Guidotti A, Davis JM, Auta J et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder, a postmortem brain study. Arch. Gen. Psychiatry57(11), 1061–1069 (2000).
   PubMed Web of Science ®Google Scholar
• Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci.6(4), 312–324 (2005).
   PubMed Web of Science ®Google Scholar
• Benes FM, Beretta S. GABAergic interneurons, implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology25(1), 1–27 (2001).
   PubMed Web of Science ®Google Scholar
• Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry61(7), 649–657 (2004).
   PubMed Web of Science ®Google Scholar
• Breese CR, Lee MJ, Adams CE. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology23(4), 351–364 (2000).
   PubMed Web of Science ®Google Scholar
• Huang HS, Matevossian A, Whittle C et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J. Neurosci.27(42), 11254–11262 (2007).
   PubMed Web of Science ®Google Scholar
• Mill J, Tang T, Kaminsky Z et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet.82(3), 696–711 (2008).
   PubMed Web of Science ®Google Scholar
• Veldic M, Kadriu B, Maloku E et al. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schiz. Res.91(1–3), 51–61 (2007).
   PubMed Web of Science ®Google Scholar
• Ruzicka WB, Zhubi A, Veldic M, Grayson DR, Costa E, Guidotti A. Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol. Psychiatry12(4), 385–397 (2007)
   PubMed Web of Science ®Google Scholar
• Grayson DR, Jia X, Chen Y et al. Reelin promoter hypermethylation in schizophrenia. Proc. Natl Acad. Sci. USA102(26), 9341–9346 (2005).
   PubMed Web of Science ®Google Scholar
• Grayson DR, Chen Y, Costa E et al. The human reelin gene, transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol. Ther.111(1), 272–286 (2006).
   PubMedGoogle Scholar
• Abdolmaleky HM, Cheng RH, Russo A et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenia patients; a preliminary report. Am. J. Med. Genet. B Neuropsychiatric Genet.134, 60–66 (2005).
   Google Scholar
• Pesold C, Liu WS, Guidotti A, Costa E, Caruncho HF. Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression. Proc. Natl Acad. Sci. USA96(6), 3217–3222 (1999).
   PubMedGoogle Scholar
• Levenson JM, Qiu S, Weeber EJ. The role of reelin in adult synaptic function and the genetic and epigenetic regulation of the reelin gene. Biochim. Biophys. Acta.1779(8), 422–431 (2008).
   PubMed Web of Science ®Google Scholar
• Dong E, Caruncho HS, Liu WS et al. A reelin–integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes. Proc. Natl Acad. Sci. USA100(9), 5479–5484 (2003).
   PubMedGoogle Scholar
• Liu WS, Pesold C, Rodriguez MA et al. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc. Natl Acad. Sci. USA98(6), 3477–3482 (2001).
   PubMed Web of Science ®Google Scholar
• Noh JS, Sharma RP, Veldic M et al. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc. Natl. Acad. Sci. USA102(5), 1749–1754 (2005).
   PubMed Web of Science ®Google Scholar
• Costa E, Dong E, Grayson DR, Guidotti A, Ruzicka W, Veldic M. Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability. Epigenetics2(1), 29–36 (2007).
   PubMed Web of Science ®Google Scholar
• Ptak C, Petronis A. Epigenetics and complex disease, from etiology to new therapeutics. Annu. Rev. Pharmacol. Toxicol.48, 257–276 (2008).
   PubMed Web of Science ®Google Scholar
• DeSilva U, D’Arcangelo G, Braden VV et al. The human reelin gene, isolation, sequencing, and mapping on chromosome 7. Genome Res.7(2), 157–164 (1997).
   PubMed Web of Science ®Google Scholar
• Bu DF, Tobin AJ. The exon–intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD. Genomics21(1), 222–228 (1994).
   PubMed Web of Science ®Google Scholar
• Straub RE, Lipska BK, Egan MF et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol. Psychiatry12(9), 854–869 (2007).
   PubMed Web of Science ®Google Scholar
• Wedenoja J, Loukola A, Tuulio-Henriksson A et al. Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol. Psychiatry13(7), 673–684 (2008).
   PubMed Web of Science ®Google Scholar
• Shifman S, Johannesson M, Bronstein M et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet.4(2), e28 (2008).
   PubMed Web of Science ®Google Scholar
• Crow TJ. How and why genetic linkage has not solved the problem of psychosis, review and hypothesis. Am. J. Psychiatry164(1), 13–21 (2007).
   PubMed Web of Science ®Google Scholar
• Sullivan PF, Lin D, Tzeng JY et al. Genomewide association for schizophrenia in the CATIE study, results of stage 1. Mol. Psychiatry13(6), 570–584 (2008).
   PubMed Web of Science ®Google Scholar
• Guidotti A, Ruzicka W, Grayson DR et al.S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport8(1), 57–60 (2007).
   Google Scholar
• Razin A, Shemer R. DNA methylation in early development. Hum. Mol. Genet.4, 1751–1755 (1995).
   PubMed Web of Science ®Google Scholar
• Szyf M, McGowan P, Meaney MJ. The social environment and the epigenome. Environ. Mol. Mutagen.49(1), 46–60 (2008).
   PubMed Web of Science ®Google Scholar
• Dong E, Guidotti A, Grayson DR, Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc. Natl Acad. Sci. USA104(11), 4676–4681 (2007).
   PubMed Web of Science ®Google Scholar
• Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc. Natl Acad. Sci. USA102(35), 12578–12583 (2005).
   PubMed Web of Science ®Google Scholar
• Tremolizzo L, Carboni G, Ruzicka WB et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc. Natl Acad. Sci. USA99(26), 17095–17100 (2002).
   PubMed Web of Science ®Google Scholar
• Tremolizzo L, Doueiri MS, Dong E et al. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol. Psychiatry57(5), 500–509 (2005).
   PubMed Web of Science ®Google Scholar
• Dong E, Nelson M, Grayson DR, Costa E, Guidotti A. Clozapine and sulpiride but not haloperidol or olanzapine activate nuclear DNA-demethylation in the brain. Proc. Natl Acad. Sci. USA105(36), 13614–13619 (2008).
   PubMed Web of Science ®Google Scholar
• Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron53(6), 857–869 (2007).
   PubMed Web of Science ®Google Scholar
• Meaney MJ, Szyf M. Maternal care as a model for experience-dependent chromatin plasticity? Trends Neurosci.28(9), 456–463 (2005).
   PubMed Web of Science ®Google Scholar
• Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J.12(11), 949–957 (1998).
   PubMed Web of Science ®Google Scholar
• Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr.32(Suppl.8), 2393S–2400S (2002).
   Google Scholar
• Wyatt RJ, Benedict A, Davis J. Biochemical and sleep studies of schizophrenia: a review of the literature 1960–1970. Schiz. Bull.1(4), 10 (1971).
   Google Scholar
• Weaver IC, Meaney MJ, Szyf M. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc. Natl Acad. Sci. USA103(9), 3480–3485 (2006).
   PubMed Web of Science ®Google Scholar
• Detich N, Bovenzi V, Szyf M. Valproate induces replication-independent active DNA demethylation. J. Biol. Chem.278(30), 27586–927592 (2003).
   PubMed Web of Science ®Google Scholar
• Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature429(6990), 457–463 (2004).
   PubMed Web of Science ®Google Scholar
• Kundakovic M, Chen Y, Costa E, Grayson DR. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol. Pharm.71, 644–653 (2007).
   PubMed Web of Science ®Google Scholar
• Scheinbart LS, Johnson MA, Gross LA, Edelstein SR, Richardson BC. Procainamide inhibits DNA methyltransferase in a human T cell line. J. Rheumatol.18(4), 530–534 (1991).
   PubMed Web of Science ®Google Scholar
• Bigey P, Ramchandani S, Therberge J et al. Transcriptional regulation of the human DNA-methyltransferase (Dnmt1) gene. Gene242, 407 (2000).
   PubMedGoogle Scholar
• Slack A, Pinar M, Aranjo FD et al. A novel regulatory element in the Dnmt1 gene that responds to co-activation by Rb and c-Jun. Gene269, 87–90 (2001).
   Google Scholar
• Deng C, Lu Q, Zhang Z et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. J. Arthritis Rheum.48, 746–756 (2003).
   PubMed Web of Science ®Google Scholar
• Satta R, Maloku E, Zhubi A, Pibiri F, Hajos M, Costa E, Guidotti A. Nicotine targets epigenetic mechanisms in selected populations of mouse telencephalic GABAergic neurons. Proc. Natl Acad. Sci. USA105(42), 16356–16361 (2008).
   PubMed Web of Science ®Google Scholar
• Sharma RP, Rosen C, Kartan S et al. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from clinical population. Schiz. Res.88, 227–231 (2006).
   PubMed Web of Science ®Google Scholar
• DeRuijter A, vanGennip A, Caron H et al. Histone deacetylases: characterization of the classical HDAC family. Biochem. J.15, 737–749 (2003).
   Google Scholar
• Simonini MV, Camargo LM, Dong E et al. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc. Natl Acad. Sci. USA103(5), 1587–1592 (2006).
   PubMed Web of Science ®Google Scholar
• Munro J, Matthiasson P, Osborne S et al. Amisulpride augmentation of clozapine, an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta Psychiatr. Scand.110(4), 292–298 (2004).
   PubMed Web of Science ®Google Scholar
• Wassef AA, Dott SG, Harris A et al. Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J. Clin. Psychopharmacol.20(3), 357–361 (2000).
   PubMed Web of Science ®Google Scholar
• Citrome L, Casey DE, Daniel DG, Wozniak P, Kochan LD, Tracy KA. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone. Psychiatr. Serv.55(3), 290–294 (2004).
   PubMed Web of Science ®Google Scholar
• Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. Psychiatr. Q.77(1), 81–95 (2006).
   PubMed Web of Science ®Google Scholar
• Guidotti A, Auta J, Davis JM et al. GABAergic dysfunction in schizophrenia: a new treatment target on the horizon. Psychopharmacology (Berl.)180, 191–205 (2005).
   PubMed Web of Science ®Google Scholar
• Mastronardi FG, Noor A, Wood DD, Paton T, Moscarello MA. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J. Neurosci. Res.85, 2006–2016 (2007).
   PubMed Web of Science ®Google Scholar